For infants under the age of 12months, if they are at high risk (+family history of peanut allergy; eczema, allergies), we are offering early introduction protocol in order to prevent them from developing a peanut allergy.
Based on the LEAP Study, regular feeding of peanut protein to children at high risk can significantly reduce the development of peanut allergy.
Make an appt for your at risk infant to be evaluated for a peanut allergy, prior to starting the introduction.
In phase 3 trials is the new peanut patch therapy. We are closely following its develop as it appears that it may be available to prescribe in the next few years. We are still awaiting for guidelines for this new therapy.
As we get underway with signing off on school forms, we are often asked about the Epipen dosing. The appropriate dosing is 0.01mg/kg however the devices (Epipen and Auvi Q) only come in 2 set doses, Jr 0.15mg and Regular 0.3mg. If your child have a severe food allergy or a nut allergy, once your child’s weight is 44lbs (20kg), we recommend moving your child up to the next dose from the Jr to regular as underdosing can lead to fatality. The increased dose may cause some transient side effects such as increased heart rate and jitteriness.
Exciting new study from England, LEAP study has shown that early introduction of peanuts (2 grams, about 8 peanuts) starting in infancy on a regular basis (3 times a week for 5 years) may be able to prevent the onset of peanut allergy for those at risk of developing a peanut allergy. The study was the first of it’s kind. Many more studies are needed to answer the numerous questions that have risen but it is a promising method that we are implementing in our practice. Recommend patients come in between 4 months and 10 months of age.
Dr. Bailey discussed this on a panel with the LEAP research physicians from London on the Diane Rehm Show WAMU 88.5FM.
This new peanut allergy study is exciting. The study treatment patients received both probiotics and oral peanut protein. At the end of the study about 80% of patients could tolerate peanuts. More research will need to be done to see if this is a permanent treatment and how oral peanut treatments can be safely provided outside of research facilities. See link below.
Traditional immunotherapy has proven to be very effective in long term treatment for environmental allergies such as tree, grass weed pollens as well as for animal dander, dustmite and molds. In Europe sublingual immunotherapy has been used and proven to work as well. Traditional immunotherapy is more potent than sublingual immunotherapy and may work better for those with strong allergies and multiple allergies, however for those who are only allergic to GRASS or only allergic to RAGWEED but are not candidates for immunotherapy injections due to a heart condition, being on beta blockers, fear of needles, busy work schedules, etc then this may be an option.
You need to have had allergy testing/evaluation with us within the past 12 months, first dose is taken in our office, monitored for 30 minutes, and then at home. Recommended as a daily or seasonal pill for 3 years. You must carry an Epipen while on this treatment.
If interested, call our office today 703-558-6040.
If you missed the live interview at noon on Channel 9 WUSA this past Wednesday, April 16th, you can still watch it on our website www.allergynva.com for some helpful tips on how to get through this allergy season.
Dr. Bailey gives interview to Paula Wolfson regarding allergy. Listen to find out how stress reduction may help your allergy symptoms.